Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
16729-525-08 · Atropine Sulfate Injection · Accord Healthcare Inc.
What is the package ndc for 16729-525-08 · Atropine Sulfate Injection · Accord Healthcare Inc.?
For 16729-525-08 · Atropine Sulfate Injection · Accord Healthcare Inc., package ndc is 16729-525-08; generic name is Atropine Sulfate Injection; manufacturer is Accord Healthcare Inc; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01.
"initial_posting_date": "01/01/2012", "package_ndc": "16729-525-08", "generic_name": "Atropine Sulfate Injection", "contact_info": "866-941-7875, option 2", "availability": "Unavailable", "related_info": "Estimated recovery: September 2026"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 16729-525-08 verified
- Generic name
- Atropine Sulfate Injection verified
- Manufacturer
- Accord Healthcare Inc. verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Estimated recovery: September 2026 verified
- Initial posting date
- 01/01/2012 verified
- Last update date
- 08/17/2026 verified
- Days in shortage
- 5357 our reading
- Reason for shortage
- Requirements related to complying with good manufacturing practices verified
- Dosage form
- Injection verified
- Therapeutic category
- Anesthesia verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/17/2026", "therapeutic_category": [ "Anesthesia", "Neurology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08)", "company_name": "Accord Healthcare Inc.", "shortage_reason": "Requirements related to complying with good manufacturing practices", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
The same source also states
"initial_posting_date": "01/01/2012", "package_ndc": "16729-525-08", "generic_name": "Atropine Sulfate Injection", "contact_info": "866-941-7875, option 2", "availability": "Unavailable", "related_info": "Estimated recovery: mid-September 2026"
— api.fda.gov, retrieved 2026-09-10
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000